News

After dropping its only clinical-stage candidate last month, ADC Therapeutics is shutting down a U.K. research site and ...
Our portfolio includes CMOS processes available from 22 nm to 180 nm (TSMC and GF), with an effective number of bits (ENOB) ranging from 12b to 20b. T ...
Lieutenant Commander Yashasvi Solanki has become the first woman officer from the Indian Navy to be appointed as Aide-de-Camp ...
The Indiana Pacers aren’t celebrating. The Oklahoma City Thunder aren’t panicking. The NBA Finals scoreboard is what it is — ...
RayzeBio, the radiopharmaceutical unit of Bristol Myers Squibb, licensed an experimental drug and diagnostic agent for prostate cancer from Philochem AG for a $350 million upfront payment. Philochem ...
Background and aims Quantifying systemic inflammation (SI) in acutely decompensated cirrhosis (ADC) is of major importance ...
I maintain a Buy rating on Zymeworks Inc. stock due to platform promise and upcoming catalysts. However, click for why I am ...
ASCO Annual Meeting is taking place in Chicago, US, from . Duality Bio (HKEX: 9606.HK) presented the preliminary ...
Medicovestor and Sanyou Biopharmaceuticals signed a strategic partnership agreement, witnessed by Medicovestor COO Lin Ong; ...
IBI354 has demonstrated promising anti-tumor efficacy and favorable safety profiles across multiple solid tumors. It not only holds potential to deliver a new generation of ADC therapies characterized ...